Download PDF
J Neurol Surg A Cent Eur Neurosurg 2016; 77(05): 452-456
DOI: 10.1055/s-0035-1558415
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Surgical Treatment Alone of Cerebral Aspergillosis in Immunocompetent Patient

Daniel Beraldo
1   Department of Nephrology, UNIFESP, São Paulo, São Paulo, Brazil
2   Department of Internal Medicine, Hospital Renascentista, Pouso Alegre, Minas Gerais, Brazil
,
Ramon Guerra
3   Department of Neurosurgery, Hospital das Clínicas Samuel Libânio, Pouso Alegre, Minas Gerais, Brazil
,
Vinícius Alvarenga
3   Department of Neurosurgery, Hospital das Clínicas Samuel Libânio, Pouso Alegre, Minas Gerais, Brazil
,
Letícia Crepaldi
3   Department of Neurosurgery, Hospital das Clínicas Samuel Libânio, Pouso Alegre, Minas Gerais, Brazil
› Author Affiliations
Further Information

Publication History

17 May 2014

31 March 2015

Publication Date:
03 August 2015 (online)

    Permissions and Reprints

Abstract

Aspergillosis is a disease that predominantly affects immunocompromised patients. The incidence in immunocompetents is rare, and manifestation is generally pulmonary. Few reports in the literature refer to isolated cerebral aspergillosis in individuals with no chronic comorbidities. We describe a case of a 59-year-old rural worker without previous pathologies who had a partial convulsive crisis in a subtle form, with self-limiting and nonrecurrent secondary generalization. Diagnostic investigation demonstrated a subcortical tumorlike lesion in the right precentral gyrus by nuclear magnetic resonance that allowed en bloc microsurgical resection, with histopathologic findings indicating cerebral aspergillosis. Because of the delay in obtaining the result of the biopsy due to technical difficulties with analysis, the diagnosis was delayed. The patient was clinically stable, with imaging without modifications and with negative serologic tests, so it was decided to follow the patient without antifungal therapy, which was successful. This was a case of isolated cerebral aspergillosis in an immunocompetent individual who was successfully treated by complete resection of the lesion alone, without combined antifungal therapy.

Keywords

aspergillosis - central nervous system - seizures
 

  • References

  • 1 Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12 (6) 1147-1201
    CrossrefPubMedGoogle Scholar
  • 2 Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54 (12) 1044-1054
    CrossrefPubMedGoogle Scholar
  • 3 Siddiqui AA, Shah AA, Bashir SH. Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases. Neurosurgery 2004; 55 (3) 602-611 ;discussion 611–613
    CrossrefPubMedGoogle Scholar
  • 4 Chernik NL, Armstrong D, Posner JB. Central nervous system infections in patients with cancer. Medicine (Baltimore) 1973; 52 (6) 563-581
    CrossrefPubMedGoogle Scholar
  • 5 Shamim MS, Enam SA, Ali R, Anwar S. Craniocerebral aspergillosis: a review of advances in diagnosis and management. J Pak Med Assoc 2010; 60 (7) 573-579
    PubMedGoogle Scholar
  • 6 Hall WA. Neurosurgical infections in the compromised host. Neurosurg Clin N Am 1992; 3 (2) 435-442
    PubMedGoogle Scholar
  • 7 Vinas FC, King PK, Diaz FG. Spinal aspergillus osteomyelitis. Clin Infect Dis 1999; 28 (6) 1223-1229
    CrossrefPubMedGoogle Scholar
  • 8 Figueiredo EG, Fonoff E, Gomes M, Macedo E, Marino Júnior R. Tumoral form of aspergillosis in central nervous system (cerebral aspergilloma): case report. Sao Paulo Med J 2003; 121 (6) 251-253
    CrossrefPubMedGoogle Scholar
  • 9 Lyons RW, Andriole VT. Fungal infections of the CNS. Neurol Clin 1986; 4 (1) 159-170
    PubMedGoogle Scholar
  • 10 Camarata PJ, Dunn DL, Farney AC, Parker RG, Seljeskog EL. Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscess: case report and review of the literature. Neurosurgery 1992; 31 (3) 575-579
    CrossrefPubMedGoogle Scholar
  • 11 Björkholm B, Elgefors B. Cerebellar aspergilloma. Scand J Infect Dis 1986; 18 (4) 375-378
    CrossrefPubMedGoogle Scholar
  • 12 Maschke M, Dietrich U, Prumbaum M , et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23 (11) 1167-1176
    CrossrefPubMedGoogle Scholar
  • 13 Sood S, Sharma R, Gupta S, Pathak D, Rishi S. Neuroaspergillosis in an immunocompetent patient. Indian J Med Microbiol 2007; 25 (1) 67-69
    CrossrefPubMedGoogle Scholar
  • 14 Speth C, Rambach G, Lass-Flörl C , et al. Culture supernatants of patient-derived Aspergillus isolates have toxic and lytic activity towards neurons and glial cells. FEMS Immunol Med Microbiol 2000; 29 (4) 303-313
    CrossrefPubMedGoogle Scholar
  • 15 Patterson TF. Approaches to fungal diagnosis in transplantation. Transpl Infect Dis 1999; 1 (4) 262-272
    CrossrefPubMedGoogle Scholar
  • 16 McGinnis MR. Detection of fungi in cerebrospinal fluid. Am J Med 1983; 75 (1B): 129-138
    PubMedGoogle Scholar
  • 17 Verweij PE, Brinkman K, Kremer HPH, Kullberg BJ, Meis JF. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 1999; 37 (4) 1186-1189
    PubMedGoogle Scholar
  • 18 Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42 (10) 1417-1427
    CrossrefPubMedGoogle Scholar
  • 19 Viscoli C, Machetti M, Gazzola P , et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 2002; 40 (4) 1496-1499
    CrossrefPubMedGoogle Scholar
  • 20 Kami M, Ogawa S, Kanda Y , et al. Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay. Br J Haematol 1999; 106 (2) 536-537
    CrossrefPubMedGoogle Scholar
  • 21 Shamim MS, Siddiqui AA, Enam SA, Shah AA, Jooma R, Anwar S. Craniocerebral aspergillosis in immunocompetent hosts: surgical perspective. Neurol India 2007; 55 (3) 274-281
    CrossrefPubMedGoogle Scholar
  • 22 Schwartz S, Thiel E. Update on the treatment of cerebral aspergillosis. Ann Hematol 2004; 83 (1) (Suppl. 01) S42-S44
    PubMedGoogle Scholar
  • 23 Schwartz S, Ruhnke M, Ribaud P , et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005; 106 (8) 2641-2645
    CrossrefPubMedGoogle Scholar
  • 24 Herbrecht R, Denning DW, Patterson TF , et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347 (6) 408-415
    CrossrefPubMedGoogle Scholar